Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Erika Carmel-TechXTAE:ERKA 32 FCF Yield % is 6.25 as of Jul. 24, 2026. GuruFocus rates XTAE:ERKA with a GF Score™ of 32/100 and a GF Value™ of ₪0.55 (Fairly Valued). The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Erika Carmel-Tech ranks better than 86.52% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Erika Carmel-Tech's FCF Yield % or its related term are showing as below:
XTAE:ERKA'
s FCF Yield % Range Over the Past 10 Years
Min: -248.85 Med: -23.36 Max: 7
Current: 6.25
During the past 8 years, the highest FCF Yield % of Erika Carmel-Tech was 7.00%. The lowest was -248.85%. And the median was -23.36%.
XTAE:ERKA's FCF Yield % is ranked better than 86.52% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: -0.42
vs XTAE:ERKA: 6.25
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Erika Carmel-Tech FCF Yield % Related Terms
Erika Carmel-Tech FCF Yield % Historical Data
* Premium members only.
The historical data trend for Erika Carmel-Tech's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTAE:ERKA vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Erika Carmel-Tech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Erika Carmel-Tech FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Erika Carmel-Tech's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Erika Carmel-Tech's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Erika Carmel-Tech (XTAE:ERKA) has a FCF Yield % of 6.25 as of Jul. 24, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Erika Carmel-Tech and its competitors. According to the industry distribution chart, Erika Carmel-Tech ranks #115 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 13.5%.
Is Erika Carmel-Tech's FCF Yield % too high?
Erika Carmel-Tech's current FCF Yield % is 6.25. Based on the distribution chart, Erika Carmel-Tech ranks #115 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Erika Carmel-Tech has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Erika Carmel-Tech's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Erika Carmel-Tech ranks #115 out of 853 companies for FCF Yield %. This places Erika Carmel-Tech in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Erika Carmel-Tech and its competitors. Erika Carmel-Tech's current FCF Yield % is 6.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Erika Carmel-Tech stock overvalued right now?
Based on GuruFocus' analysis, Erika Carmel-Tech (XTAE:ERKA) is currently considered Fairly Valued. The stock's GF Value™ is ₪0.55, compared to a current price of ₪0.52 — trading 6.4% below its estimated fair value. The current FCF Yield % is 6.25. Erika Carmel-Tech's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Erika Carmel-Tech (XTAE:ERKA), the current FCF Yield % is 6.25 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Erika Carmel-Tech (XTAE:ERKA) Overvalued in 2026?
Based on GuruFocus' analysis, Erika Carmel-Tech stock appears to be undervalued.
The current stock price of ₪0.52 is trading 6.4% below its estimated GF Value™ of ₪0.55.
GuruFocus considers Erika Carmel-Tech to be Fairly Valued.
Key valuation signals for XTAE:ERKA:
FCF Yield %: 6.25
GF Value™: ₪0.55 vs. price of ₪0.52 (6.4% below fair value)
No single metric tells the full story. See the XTAE:ERKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Erika Carmel-Tech Ltd Formerly Erika B-Cure Laser Ltd is engaged in the development and production of laser devices for the treatment of pain and wounds. Its devices provide treatment for Knee Pain, Lower Back Pain, Neck Pain, Shoulder Pain, Finger Joint pain, and Burns.
32GF Score
Get the complete analysis for XTAE:ERKA
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ERKA has been successfully added to your 
